Table 3:
Subject CI device information
N (%) | ||
---|---|---|
CI company | Advanced Bionics | 43 (11.5%) |
Cochlear | 216 (58.2%) | |
MED-EL | 112 (30.1%) | |
Listening Modality | Unilateral CI with no contralateral HA | 87 (23.4%) |
Unilateral CI with hearing aid | 96 (25.8%) | |
Bilateral CI | 188 (50.6%) | |
Combined electro-acoustic hearing (Hybrid) | No | 358 (96.4%) |
Yes | 12 (3.2%) | |
No response | 1 (0.2%) |